Dotmatics (FKA Insightful Science GraphPad)
AcquiredConnect science, data, and decision-making
San Diego, United States · Founded 2005 · $11.3M raised
- Headquarters
- San Diego, California
- Employees
- 501–1000
- Founded
- 2005
- Business Model
- B2B
- Website
- dotmatics.com
- Total Funding
- $11.3M
- Last Round
- $3.8M SeedMar 2021
- Rounds
- 3
About
Dotmatics is a scientific R&D software platform used by over 2 million scientists across 10,000+ organizations globally. Founded in 2005, the company offers an integrated suite of tools spanning biology, chemistry, and materials science — including SnapGene, Geneious, GraphPad Prism, and LabArchives — unified under its AI-native Luma platform for multimodal scientific data management, workflow automation, and decision-making. Dotmatics serves leading pharmaceutical companies, biotechs, chemical manufacturers, and academic institutions. The company was acquired by Siemens in a $5.1 billion deal to strengthen Siemens' position in AI-powered life sciences R&D software.
Summary
Dotmatics (FKA Insightful Science GraphPad) is a Biotech company based in San Diego, United States, founded in 2005. It has raised $11.3M in total across 3 rounds, most recently a $3.8M Seed round in Mar 2021. Investors include Insight Partners, Siemens AG and Scottish Equity Partners.
Tech & App Stack
7 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...